Stevenage, United Kingdom

Christopher Williamson


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Dartford, GB (1997)
  • Stevenage, GB (2001)

Company Filing History:


Years Active: 1997-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Christopher Williamson

Introduction

Christopher Williamson is an accomplished inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical formulations through his innovative work on N-acetyl neuraminic acid derivatives. With a total of 2 patents, Williamson's inventions are paving the way for advancements in drug development.

Latest Patents

Williamson's latest patents include "Crystalline N-acetyl neuraminic acid derivatives and process for their preparation." This patent describes two useful crystal hydrates of 5-acetamido-2,3,4,5-tetradeoxy-4-guanidino-D-glycero-D-galacto-non-2-enopyranosonic acid, which exhibit either a low or high aspect ratio. These crystalline derivatives are particularly favored for pharmaceutical formulation due to their advantageous physical properties. For instance, the low aspect ratio crystal demonstrates excellent flow properties, while the high aspect ratio crystal maintains a stable water content over time.

Another significant patent is the "Process for the preparation of N-acetyl neuraminic acid derivatives." This process further enhances the utility of these compounds in various applications.

Career Highlights

Williamson is currently employed at Biota Scientific Management Pty Ltd, where he continues to innovate and contribute to the field. His work is characterized by a commitment to improving pharmaceutical formulations and enhancing the efficacy of drug delivery systems.

Collaborations

Throughout his career, Williamson has collaborated with notable colleagues, including Andrew David Searle and William James White. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Christopher Williamson's contributions to the field of pharmaceutical formulations through his patents on N-acetyl neuraminic acid derivatives highlight his role as a leading inventor. His work not only advances scientific knowledge but also has practical implications for drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…